The study was registered in the Iranian Clinical Trial Center "irct.ir" with the registration code of "IRCT138810192804N3". The study plan was approved by IRB ethics committee, Research Deputy, Tehran University of Medical Sciences, Tehran, Iran. The location of the study was a university affiliated hospital in Iran from 2008 to 2010. After taking informed written consent from patients scheduled for elective in vitro fertilization (IVF) in OBGYN ward, 200 were selected and entered the study in a randomized clinical trial method. Sample size calculation and statistical methods: sample size determination was performed after a power analysis in which power = 0.8, α = 0.05 and β = 0.2. After that, the following equation was used to determine the sample size: The sample size (i.e. 200 study patients) was randomly assigned into two groups using simple randomization (the table of random numbers). All continuous data with normal distribution were expressed as mean ± SD and categorical variables were expressed as percentage. The continuous variables were compared using the student t-test. Type of anesthesia (GA vs. spinal), duration of anesthesia (in minutes), and age (in years) were considered as independent variables. Also, other Nonparametric and parametric tests were used for data analysis; including the Kolmogorov-Smirnov, Pearson Chi-square, and Fisher exact tests. All statistical analyses were performed by SPSS software (Version 11.5, SPSS, Inc, Chicago, IL). P value less than 0.05 was considered significant.
The study patients were divided into two groups. So, after using random table of numbers, 100 patients were allocated in each group. For this process, during a two year period, women aged 20 to 40 years were selected and after considering the inclusion and exclusion criteria, entered the study. The inclusion criteria were as follows: elective surgery, informed written consent for performing anesthesia in the form of general or spinal. Exclusion criteria were patient refusal for entering the study, lack of appropriate NPO time, any contraindication for performing spinal anesthesia including patient refusal for spinal anesthesia, spinal deformities, previous spinal surgery, preexisting coagulopathy, platelet disorders, and chronic pain syndromes, history of drug abuse, cardiovascular diseases and uncontrolled hypertension. Also, some factors such as diabetes mellitus, thyroid diseases and smoking may create some effects on success rate; so, they were considered as exclusion criteria of the study.
All the patients had the same therapeutic protocols for ovum retrieval; which was the long protocol. Also, all of them had the same surgical process with the same physicians. For assuring the oneness of the surgeon, all the patients were operated by only one of the surgeons. Also, all the patients underwent the same procedure to ensure the oneness of the surgical procedure. For anesthesia, the first group, received spinal anesthesia for performing In Vitro Fertilization (IVF), and the other group received general anesthesia for this purpose. In the spinal anesthesia group, the patients first were monitored using standard electrocardiography, noninvasive blood pressure, pulse oximetry and heart rate monitoring. Then, 500 mL of isotonic saline was administered, and while a guardian nurse was holding the patient, in the sitting position and under sterile conditions, between the 3rd and 4th lumbar interspaces, a number 25 Quincke needle was introduced and 75 mg of pure 2% lidocaine, without any additive or preservatives was injected into the subarachnoid space. The patients were turned immediately to supine position to gain a T10 (10th thoracic) level of anesthesia. The anesthesia level and the blood pressure were checked continually.
For the general anesthesia (GA) group, each patient was in supine position in operation room. Then, standard monitoring was used including pulse oximetry, pulse rate, noninvasive blood pressure (NIBP) monitoring and 3 lead electrocardiogram monitoring. Also, clinical monitoring of respiratory status was constantly performed. Afterwards, using fentanyl (1 µg/kg) and midazolam (30µg/kg) intravenously as premedication drugs, induction of GA was administered by incremental intravenous doses of thiopental (4 mg/kg) and atracurium (0.5 mg/kg). The trachea was intubated using a low pressure high volume tube (size 7) by direct laryngoscopy. The tracheal tube cuff was filled by air to 15-20 cm-H2O pressure until minimal leak occurred. The anesthesia was maintained by isoflurane (0.8-1 MAC). The residual of muscle relaxant was reversed by atropine (0.03 mg/kg) and neostigmine (0.07 mg/kg) after detection of minimal muscle contractions at the end of the procedure. The patients were extubated in fully awake and stable clinical condition.
Patient evaluation for the results of pregnancy outcome was performed by a different team who were unaware of patient group allocation. The evaluating teams were different from the executive team and evaluated the patients separately at two weeks and six weeks after IVF accordingly. The patients were evaluated regarding the pregnancy outcome using serum β-hCG test two weeks after IVF and sonographic evaluation six weeks after IVF. All the evaluations were performed by the same setting. Pregnancy confirmation was performed after approval of the two tests. The number of fertilized oocytes and embryos transferred in each group and also, the duration in which embryos were outside the controlled environments were kept similar as much as possible.